Singapore, Singapore

Rajeev Gokhale

This inventor holds 5 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignees: Abbvie Inc., National University of Singapore, Other. Active years: 2013-2026.

USPTO Granted Patents = 5 

% Patents Active = 60.0


 

Average Co-Inventor Count = 12.1

ph-index = 3

Forward Citations = 30(Granted Patents)


Location History:

  • Helios, SG (2013)
  • Singapore, SG (2016 - 2018)

Company Filing History:


Years Active: 2013-2026

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Rajeev Gokhale: Innovator in Antiviral Dosage Forms

Introduction

Rajeev Gokhale is a prominent inventor based in Singapore, known for his contributions to the field of antiviral medications. With a total of 5 patents to his name, he has made significant strides in developing solid dosage forms that effectively combat viral infections.

Latest Patents

Gokhale's latest patents focus on solid antiviral dosage forms. The present disclosure relates to solid dosage forms comprising antiviral compounds and methods of using such dosage forms to treat antiviral infections. His innovative approach aims to enhance the efficacy of antiviral treatments, providing new options for patients.

Career Highlights

Throughout his career, Rajeev Gokhale has worked with notable companies, including AbbVie Inc. and Roquette Frères. His experience in these organizations has allowed him to refine his expertise in pharmaceutical development and contribute to groundbreaking research in antiviral therapies.

Collaborations

Gokhale has collaborated with various professionals in the field, including his coworker Eric Allen Schmitt. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Rajeev Gokhale's work in developing solid antiviral dosage forms showcases his commitment to advancing medical science. His contributions are vital in the ongoing fight against viral infections, and his patents reflect a dedication to improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…